Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
08/14/2017 08/16/2017 08/17/2017 08/18/2017 08/21/2017 Date
71.65(c) 71.4(c) 71.7(c) 71.55(c) 71.35 Last
58 212 68 456 60 605 48 714 32 790 Volume
+1.34% -0.35% +0.42% -0.21% -0.28% Change
More quotes
Financials (€)
Sales 2017 643 M
EBIT 2017 199 M
Net income 2017 135 M
Finance 2017 70,3 M
Yield 2017 1,25%
Sales 2018 699 M
EBIT 2018 218 M
Net income 2018 149 M
Finance 2018 130 M
Yield 2018 1,35%
P/E ratio 2017 29,29
P/E ratio 2018 26,58
EV / Sales2017 6,10x
EV / Sales2018 5,52x
Capitalization 3 991 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
07/28 DIASORIN LAUNCHES 3 NEW PRIMER PAIRS : Pneumocystis jirovecii, group c streptoco..
07/25 DIASORIN : To acquire elisa immunodiagnostic business portfolio and associated a..
07/10 DIASORIN : launches IAM CBFB-MYH11, completing the diagnostic test menu for mole..
07/06 DIASORIN : Showcases the Benefits of Utilizing Available Biomarkers to Tailor an..
06/30 DIASORIN : Authorizations of Emergency Use of In Vitro Diagnostic Devices for De..
06/30 DIASORIN : and Tecan to collaborate in new platform development
06/29 DIASORIN : and Tecan to collaborate in new platform development
06/22 DIASORIN : and QIAGEN sign collaboration to expand Liaison test menu through ado..
06/14 DIASORIN : Modification to a Previous Presolicitation Notice - DiaSorin Reagent ..
06/14 DIASORIN : Explores the Relationship of Growth Hormones and the Adult Skeleton
More news
Sector news : Diagnostic & Testing Substances
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second-q..
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second q..
07/28 Tech sector depresses European shares on busy earnings day
07/28 ESSILOR INTERNATIONAL : sticks to profitability target despite dip in sunglasses..
07/27 SMITH & NEPHEW : buoyed by double-digit emerging markets growth
More sector news : Diagnostic & Testing Substances
Latest Tweets
07/25DiaSorin fa shopping da Siemens Healthcare per 47,5 milioni  
06/26DiaSorin, i target per il triennio 2017/2019 (SoldiOnline.it)  
06/22BRIEF-Diasorin, Qiagen to develop tests for Diasorin's family of analyzers  
06/22BRIEF-Diasorin signs collaboration with QIAGEN to expand LIAISON test menu  
05/26DiaSorin : reports growth in revenues and profitability in the first quarter .. 
More tweets
Qtime:3
News from SeekingAlpha
06/27 DiaSorin (DSRLF) Investor Presentation - Slideshow
2016 Winner And Losers Among Italian Companies
2016 Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides
2016 DiaSorin buys Quest's diagnostic products business for $300M
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 71,2 €
Spread / Average Target -0,50%
EPS Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA27.20%4 708
BIOMÉRIEUX30.97%8 623
AUTOBIO DIAGNOSTICS CO LTD-21.06%2 740
MACCURA BIOTECHNOLOGY CO LTD--.--%2 145
SHANGHAI KEHUA BIO-ENGINEERING CO LTD--.--%1 282
SIEGFRIED HOLDING AG31.92%1 226